Questions with the most recent answer or edit.
What I have: mazdutide · sixteen weeks · minus 20 °C. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me…
The case in front of me: QST · Zhuhai Kerui Biotechnology. I would like the axes of comparison first and the recommendation second. I have tried the first option and…
I have three data points across nine months, which I hope is enough to see a trend. This is presented as though it settles something, and I am not convinced it does.…
Stated plainly: 97.9% · batch certificate. I have read the primary source rather than the summary, which has left me with more questions. I understand the headline. I…
I have read the prescribing information and it addresses the adjacent case but not this one. I can parse the result. I am less sure what it licenses me to conclude. I…
For reference: minus 80 °C · ecnoglutide. I would like to know whether this claim survives contact with evidence. If the answer is "nobody has tested that", I would…
Stated plainly: FGP · a GLP-1 receptor agonist. This is not behaving the way I expected and I want to understand the discrepancy before I act on it. I have…
I have three data points across nine months, which I hope is enough to see a trend. This is presented as though it settles something, and I am not convinced it does.…
Stated plainly: orforglipron · 20 mg/mL · sixteen weeks. This is asserted often enough that I assumed it was established, and then I went looking for the source. I…
For reference: 4 mg · 5 mL · phosphate-buffered diluent · orforglipron. I am at the decision point and I would rather think it through than improvise. I would rather…
Numbers first: mazdutide · STEP 3. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree,…
What I have: racemisation · 25 °C. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have a boring answer. I would still…
The particulars: 99.1% · PeptideMeter · 98.8% · Medutest. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read the arguments…
Concretely: survodutide · method section. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single…
What I am working with: 60 mg · 0.5 mL · bacteriostatic water. I have worked this out and I would like someone to find the error, because I suspect there is one. My…
The specifics, since they change the answer: QYB · Chengdu · Canada. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan…
The method section is present, which is unusual enough that I want to make use of it. I would like help reading this properly rather than being told what conclusion…
For reference: liraglutide · TRIUMPH-3. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am…
I have the report as a PDF with the chromatogram on page two, so I can quote specifics. I am asking for verification rather than opinion, ideally with something I can…
Setup, so nobody has to ask: creatinine · cagrilintide. I am trying to build something sustainable rather than something thorough that I will abandon. I have already…
The particulars: tirzepatide · room temperature. I want a method I can write down and repeat, not a rule of thumb. I would rather over-engineer this than discover a…
I have the full paper rather than the abstract, and the supplementary appendix. I have the document in front of me and I can read the numbers. What I cannot do is…
The specifics, since they change the answer: 25 °C · ecnoglutide. Somebody stated this to me confidently and I would like to check it before repeating it. I would…
I have continuous temperature data for the period in question, which is unusual and I would like to use it. I have a result I cannot explain, and I would rather…